BDSI


William Blair Reiterates Upbeat View Of BioDelivery Sciences International, Inc. Following Exclusive TennCare Agreement

In a research report released Tuesday, William Blair analyst Tim Lugo reiterated an Outperform rating on shares of BioDelivery Sciences International, Inc. (NASDAQ:BDSI) with a …

Janney Montgomery Pounds The Table On BioDelivery Sciences International, Inc. (BDSI)

Janney Montgomery’s healthcare analyst Chiara Russo was out pounding the table on BioDelivery Sciences International, Inc. (NASDAQ:BDSI), reiterating a Buy rating and price target of …

Biodelivery Sciences: Onsolis Re-Partnering Offers Upside, Says Roth Capital

Roth Capital analyst Scott Henry reiterated a Buy rating on Biodelivery Sciences (NASDAQ:BDSI) with a price target of $18.00, as the company announced that it …

William Blair Reiterates Outperform On Biodelivery As It Acquires North American Rights To Pain Patch

In a research report sent to investors, William Blair analyst Tim Lugo reiterated an Outperform rating on Biodelivery Sciences (NASDAQ:BDSI) with a price …

Roth Capital Cuts Biodelivery Price Target To Reflect More Conservative Bunavail Launch Assumptions

In a research report published Friday, Roth Capital analyst Scott Henry upgraded shares of Biodelivery Sciences (NASDAQ:BDSI) from Hold to Buy rating, but reduced his …

William Blair Reiterates Outperform On Biodelivery Sciences Following Management Meetings With investors

In a research report published today, William Blair analyst Tim Lugo reiterated an Outperform rating on Biodelivery Sciences (NASDAQ:BDSI) with a $25 price …

Biodelivery: We Remain On The Sidelines Pending A Few More Weeks Of Bunavail Prescriptions, Say Roth Capital

Roth Capital analyst Scott Henry maintained a Neutral rating on Biodelivery Sciences (NASDAQ:BDSI) with a $20 price target, which represents a potential upside …

Roth Capital Downgrades BioDelivery To Neutral As Upside Seems Limited At Current Levels

In a research note released this morning, Roth Capital analyst Scott Henry downgraded shares of BioDelivery Sciences (NASDAQ:BDSI) from a Buy rating to …

William Blair Remains Bullish On BioDelivery Following Launch Update

In a research report issued Wednesday, William Blair analyst Tim Lugo maintained an Outperform rating on BioDelivery Sciences International (NASDAQ:BDSI) with a $25 price …

BioDelivery Sciences Remains A Top Pick Within Our Coverage, Says William Blair

In a research report published yesterday, William Blair analyst Tim Lugo maintained an Outperform rating on BioDelivery Sciences (NASDAQ:BDSI) with a $25 price …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts